This article is part of the supplement: 29th International Symposium on Intensive Care and Emergency Medicine
Analysis of the off-licence use of recombinant activated factor VII for patients with uncontrolled haemorrhage in a UK tertiary referral hospital
Critical Care 2009, 13(Suppl 1):P432 doi:10.1186/cc7596